$3.4 Billion is the total value of Kohlberg Kravis Roberts & Co. L.P.'s 79 reported holdings in Q2 2014. The portfolio turnover from Q1 2014 to Q2 2014 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| WAG | WALGREEN CO | $476,236,000 | +12.3% | 6,424,340 | 0.0% | 14.00% | +96.9% | |
| KKR | KKR & CO L P DEL | $113,552,000 | +6.5% | 4,667,166 | 0.0% | 3.34% | +86.8% | |
| AMED | AMEDISYS INC | $80,965,000 | +12.4% | 4,836,608 | 0.0% | 2.38% | +97.3% | |
| AEC | ASSOCIATED ESTATES RLTY CORP | $40,323,000 | +6.4% | 2,237,688 | 0.0% | 1.19% | +86.5% | |
| JNK | SPDR SERIES TRUSTbrc hgh yld bd | $12,532,000 | +1.0% | 300,300 | 0.0% | 0.37% | +76.9% | |
| AKORN INCnote 3.500% 6/0 | $12,217,000 | +35.4% | 3,500,000 | 0.0% | 0.36% | +137.7% | ||
| AMP | AMERIPRISE FINL INC | $5,556,000 | +9.0% | 46,300 | 0.0% | 0.16% | +91.8% | |
| BRISTOL MYERS SQUIBB COdbcv 9/1 | $4,838,000 | -8.6% | 3,894,000 | 0.0% | 0.14% | +59.6% | ||
| BCSPRDCL | BARCLAYS BANK PLCadr pfd sr 5 | $2,107,000 | -0.6% | 81,469 | 0.0% | 0.06% | +72.2% | |
| ESSX | ESSEX RENT CORP | $972,000 | -17.9% | 400,000 | 0.0% | 0.03% | +45.0% | |
| TBF | PROSHARES TRshrt 20+yr tre | $576,000 | -5.1% | 20,000 | 0.0% | 0.02% | +70.0% | |
| LO | LORILLARD INC | $305,000 | +13.0% | 5,000 | 0.0% | 0.01% | +80.0% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- KKR Investment Management LLC #1
- KKR Asset Management LLC #2
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| COHERUS BIOSCIENCES INC | 34 | Q2 2024 | 1.4% |
| RIGNET INC | 30 | Q1 2021 | 7.5% |
| KKR REAL ESTATE FIN TR INC | 29 | Q2 2024 | 7.7% |
| MADISON SQUARE GRDN SPRT COR | 26 | Q2 2024 | 1.9% |
| BRIGHTVIEW HLDGS INC | 25 | Q2 2024 | 15.5% |
| LAUREATE EDUCATION INC | 23 | Q3 2022 | 7.0% |
| PROSHARES TR | 22 | Q3 2018 | 0.0% |
| VERSO CORP | 22 | Q4 2021 | 0.0% |
| BRIDGEBIO PHARMA INC | 21 | Q2 2024 | 37.1% |
| AMEDISYS INC | 21 | Q4 2018 | 4.4% |
View Kohlberg Kravis Roberts & Co. L.P.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-30 |
| 13F-HR | 2024-08-14 |
| 4 | 2024-07-29 |
| 3 | 2024-07-24 |
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| 13F-HR/A | 2024-01-22 |
| 40-6B | 2023-12-20 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
View Kohlberg Kravis Roberts & Co. L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.